Emmanuel Mitry
Registre des Cancers digestifs
Faculté de médecine
7 boulevard Jeanne d'Arc
BP 87900
France
Name/email consistency: high
- Improvement in colorectal cancer survival: a population-based study. Mitry, E., Bouvier, A.M., Esteve, J., Faivre, J. Eur. J. Cancer (2005)
- Combination of folinic acid, 5-fluorouracil bolus and infusion, and cisplatin (LV5FU2-P regimen) in patients with advanced gastric or gastroesophageal junction carcinoma. Mitry, E., Taïeb, J., Artru, P., Boige, V., Vaillant, J.N., Clavero-Fabri, M.C., Ducreux, M., Rougier, P. Ann. Oncol. (2004)
- Predictive factors of survival in patients with advanced colorectal cancer: an individual data analysis of 602 patients included in irinotecan phase III trials. Mitry, E., Douillard, J.Y., Van Cutsem, E., Cunningham, D., Magherini, E., Mery-Mignard, D., Awad, L., Rougier, P. Ann. Oncol. (2004)
- Benefit of operative mortality reduction on colorectal cancer survival. Mitry, E., Bouvier, A.M., Esteve, J., Faivre, J. Br. J. Surg (2002)
- Effect of age, period of diagnosis and birth cohort on large bowel cancer incidence in a well-defined French population, 1976-1995. Mitry, E., Benhamiche, A.M., Couillault, C., Roy, P., Faivre-Finn, C., Clinard, F., Faivre, J. Eur. J. Cancer Prev. (2002)
- The treatment of undifferentiated neuroendocrine tumors. Mitry, E., Rougier, P. Crit. Rev. Oncol. Hematol. (2001)